Evidence map›Paper›PMID 42870104›Full record

ArticleJournal of applied genetics2026

Transcriptome profiling of Saccharomyces cerevisiae under 3-bromopyruvate treatment.

Magdalena Cal-Smok, Jakub Suchodolski, Irwin Matyjaszczyk, Agata Piecuch, Rafał Ogórek

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of applied genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Magdalena Cal-SmokDepartment of Mycology and Genetics, University of Wrocław, 63 Przybyszewskiego Str, Wrocław, 51-148, Poland. magdalena.cal@uwr.edu.pl.ORCID http://orcid.org/0000-0003-0446-0381
Jakub SuchodolskiDepartment of Mycology and Genetics, University of Wrocław, 63 Przybyszewskiego Str, Wrocław, 51-148, Poland.
Irwin MatyjaszczykDepartment of Mycology and Genetics, University of Wrocław, 63 Przybyszewskiego Str, Wrocław, 51-148, Poland.
Agata PiecuchDepartment of Mycology and Genetics, University of Wrocław, 63 Przybyszewskiego Str, Wrocław, 51-148, Poland.
Rafał OgórekDepartment of Mycology and Genetics, University of Wrocław, 63 Przybyszewskiego Str, Wrocław, 51-148, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study provides the first transcriptomic analysis of yeast Saccharomyces cerevisiae exposed to. 3-bromopyruvate (3-BP), focusing on its dose-dependent effects. RNA-Seq analysis was performed using next-generation sequencing. The results showed a positive correlation between 3-BP concentration and the extent of transcriptomic changes, consistent with prior findings that higher 3-BP levels amplify cellular effects. Significant changes across fourteen categories of biological processes were identified, particularly involving genes linked to cell cycle regulation and organic compound metabolism alongside downregulation of key metabolic regulators, including the gene encoding hexokinase 2 (HXK2). The transcriptomic profile aligns with known experimental evidence of 3-BP activity, thereby confirming its impact on key metabolic processes such as glycolysis, alternative carbon metabolism, oxidative phosphorylation, and cellular stress response. What is more, due to the observed altered expression of several transcription factor genes we hypothesize that the pleiotropic effect of 3-BP molecular action may arise from its impact on their regulatory roles.

Indexed as

3-bromopyruvate (3-BP)Gene expression regulationGlobal metabolism disruptionSaccharomyces cerevisiae, transcriptomeStress response

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.